PMID- 17495224 OWN - NLM STAT- MEDLINE DCOM- 20070705 LR - 20220316 IS - 1524-4571 (Electronic) IS - 0009-7330 (Linking) VI - 100 IP - 12 DP - 2007 Jun 22 TI - Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. PG - 1703-11 AB - Heme oxygenase (HO-1) is the rate-limiting enzyme in the catabolism of heme, which leads to the generation of biliverdin, iron, and carbon monoxide. It has been shown to have important antioxidant and antiinflammatory properties that result in a vascular antiatherogenic effect. To determine whether HO-1 expression in macrophages constitutes a significant component of the protective role in atherosclerosis, we evaluated the effect of decreased or absent HO-1 expression in peritoneal macrophages on oxidative stress and inflammation in vitro, and the effect of complete deficiency of HO-1 expression in macrophages in atherosclerotic lesion formation in vivo. We found that compared with HO-1(+/+) controls, peritoneal macrophages from HO-1(-/-) and HO-1(+/-) mice exhibited (1) increased reactive oxygen species (ROS) generation, (2) increased proinflammatory cytokines such as monocyte chemotactic protein 1 (MCP-1) and interleukin 6 (IL-6), and (3) increased foam cell formation when treated with oxLDL, attributable in part to increased expression of scavenger receptor A (SR-A). Bone marrow transplantation experiments performed in lethally irradiated LDL-R null female mice, reconstituted with bone marrow from HO-1(-/-) versus HO-1(+/+) mice, revealed that HO-1(-/-) reconstituted animals exhibited atherosclerotic lesions with a greater macrophage content as evaluated by immunohistochemistry and planimetric assessment. We conclude that HO-1 expression in macrophages constitutes an important component of the antiatherogenic effect by increasing antioxidant protection and decreasing the inflammatory component of atherosclerotic lesions. FAU - Orozco, Luz D AU - Orozco LD AD - Department of Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. FAU - Kapturczak, Matthias H AU - Kapturczak MH FAU - Barajas, Berenice AU - Barajas B FAU - Wang, Xuping AU - Wang X FAU - Weinstein, Michael M AU - Weinstein MM FAU - Wong, Jack AU - Wong J FAU - Deshane, Jessy AU - Deshane J FAU - Bolisetty, Subhashini AU - Bolisetty S FAU - Shaposhnik, Zory AU - Shaposhnik Z FAU - Shih, Diana M AU - Shih DM FAU - Agarwal, Anupam AU - Agarwal A FAU - Lusis, Aldons J AU - Lusis AJ FAU - Araujo, Jesus A AU - Araujo JA LA - eng GR - T32 HG002536/HG/NHGRI NIH HHS/United States GR - HL068157/HL/NHLBI NIH HHS/United States GR - HL30568/HL/NHLBI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070510 PL - United States TA - Circ Res JT - Circulation research JID - 0047103 RN - 0 (Antioxidants) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-6) RN - 0 (Reactive Oxygen Species) RN - 0 (Receptors, LDL) RN - 0 (Scavenger Receptors, Class A) RN - EC 1.14.14.18 (Heme Oxygenase-1) SB - IM MH - Animals MH - Antioxidants/metabolism MH - Atherosclerosis/*metabolism/pathology/*prevention & control MH - Bone Marrow Transplantation/pathology MH - Chemokine CCL2/metabolism MH - Foam Cells/pathology MH - Gene Expression Regulation MH - Gene Expression Regulation, Enzymologic MH - Heme Oxygenase-1/*metabolism MH - Interleukin-6/metabolism MH - Macrophages/*enzymology/pathology MH - Mice MH - Oxidative Stress/physiology MH - Reactive Oxygen Species/metabolism MH - Receptors, LDL/genetics/physiology MH - Scavenger Receptors, Class A/genetics/physiology EDAT- 2007/05/15 09:00 MHDA- 2007/07/06 09:00 CRDT- 2007/05/15 09:00 PHST- 2007/05/15 09:00 [pubmed] PHST- 2007/07/06 09:00 [medline] PHST- 2007/05/15 09:00 [entrez] AID - CIRCRESAHA.107.151720 [pii] AID - 10.1161/CIRCRESAHA.107.151720 [doi] PST - ppublish SO - Circ Res. 2007 Jun 22;100(12):1703-11. doi: 10.1161/CIRCRESAHA.107.151720. Epub 2007 May 10.